Skip to main content

Steven Patierno

Charles D. Watts Distinguished Professor of Medicine
Medicine, Medical Oncology
DUMC-3917, Durham, NC 27710
10 Bryan Searle Drive, Seeley Mudd Building, Suite 413, Durham, NC 27710

Overview


Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

Current Appointments & Affiliations


Charles D. Watts Distinguished Professor of Medicine · 2023 - Present Medicine, Medical Oncology, Medicine
Professor of Medicine · 2013 - Present Medicine, Medical Oncology, Medicine
Professor in Family Medicine and Community Health · 2013 - Present Family Medicine and Community Health, Clinical Science Departments
Professor of Pharmacology and Cancer Biology · 2013 - Present Pharmacology & Cancer Biology, Basic Science Departments
Member of the Duke Cancer Institute · 2012 - Present Duke Cancer Institute, Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Institutes and Centers

In the News


Published July 11, 2024
Duke Team Helps Thousands of Smokers Beat Their Addiction
Published May 4, 2023
Duke Awards 44 Distinguished Professorships
Published April 15, 2022
Duke Celebrates 50 Years of Cancer Care — and Looks Toward the Next 50

View All News

Recent Publications


Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis

Other · November 24, 2025 <div>Abstract<p>Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains hi ... Full text Cite
View All Publications

Recent Grants


2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030

Duke University Program in Environmental Health

Inst. Training Prgm or CMEMentor · Awarded by National Institute of Environmental Health Sciences · 2019 - 2029

Elucidating the role of transcriptomics in colorectal cancer disparities across diverse populations

ResearchCo Investigator · Awarded by Cedars Sinai Medical Center · 2024 - 2029

View All Grants

Education, Training & Certifications


University of Texas Medical School, Houston · 1985 Ph.D.
University of Connecticut · 1981 B.S.